Background: Although coronary calcium assessment has been demonstrated to be strongly associated with significant coronary artery disease (CAD) and future cardiac events, it is still not clear whether zero calcium on CT scan can exclude significant CAD and eliminate the need for further multi-detector computed tomography (MDCT) coronary angiography (CCTA). The purpose of this study is to test the hypothesis that zero coronary calcium on MDCT does not exclude significant CAD and CCTA is required to exclude CAD in diverse populations who have a zero calcium score.
BACKGROUND AND INTRODUCTION
Age-and sex-specific calcium score percentiles have been demonstrated to be a significant predictor for coronary events and incrementally added to the prognostic value of traditional risk factors for coronary artery disease (CAD) [1, 2] . However, the incidence of significant CAD, and subsequent cardiac events in patient with a zero coronary calcium score are not negligible and vary from <1% -16% during the follow-up period (up to 10 years) [3] [4] [5] . Furthermore, a limited number of published data on computer tomography (CT) coronary angiography has shown that significant CAD was found in a significant portion of patients with no or minimal coronary calcium, particularly in patients with chest pain or clinical suspicion of ischemic heart disease [3] [4] [5] [6] [7] . However, these studies included mostly Caucasian populations [3] [4] [5] [6] [7] [8] [9] [10] . Since significant difference in association of coronary calcium with significant coronary disease has been reported in patients with different races (MESA) [11] , incidence of significant coronary artery stenosis is still unknown in non-caucasian patients who have no detectable calcium on CT calcium scan. Consequently, it is still not clear whether patients referred for suspicion of CAD, who have no calcium on multi-detector CT (MDCT) scan should undergo coronary CT angiography (CCTA) to exclude significant coronary artery stenosis.
The purposes of the present study are to examine the incidence of significant CAD in a diverse patient cohort with different races, ages and gender who underwent CCTA, and to test the hypothesis that zero coronary calcium score on MDCT calcium scan does not exclude significant coronary artery disease and CT coronary angiogram is required to exclude coronary artery disease even in clinically suspicious patients with a zero or minimal calcium score.
PATIENTS AND METHODS
There were 791 patients referred for CCTA during June 1, 2005 to January 31, 2007 for clinically suspicious CAD with chest pain, abnormal stress test or combination of both with intermediate or low probability of CAD. Of these patients, 6 patients were excluded due to severe renal dysfunction (GFR < 15 mL/min) without dialysis. CCTA was performed in 785 patients, 48 patients were excluded with either inadequate imaging quality for interpretation of CCTA in 13 patients with motion artifacts or unable to hold breath, significant arrhythmia with atrial fibrillation or frequent premature beats in 5 patients, inability to quantify calcium score in 16 patients with coronary stent implantation or coronary bypass surgery with metal clips at the anastomosis site in 14 patients. There were 737 patients ( Table 1 ) who were included in this study. Patients with ST segment elevation were not considered with an indication for CCTA at Newark Beth Israel Medical Center and were not studied.
CT Coronary Angiography and Pre-Test Preparation
Beta-blocker (IV or oral) or calcium channel blocker (if patient had contraindications to beta-blockade) was used if heart rate >60 BPM unless a history of severe left ventricular or right ventricular dysfunction or decompensated congestive heart failure, or blood pressure <95/60 mmHg was present. Sublingual nitroglycerin (NTG, 0.4 mg) was given routinely to dilate coronary arteries and to optimize imaging quality if there were no contraindications (severe aortic valve stenosis, IHSS, allergy to NTG, BP <95/60 mmHg, or on medications such as sildenafil). Anaphylactic allergy to contrast agent was considered a contraindication to CT coronary angiography. Pre-medication was used in patients with nonanaphylactic contrast allergy or in patients with allergies to shellfish. Pre-medication included three agents IV (solumedrol 120 mg, benadryl 50 mg, and pepcid 20 mg) which were given at least 15 minutes before cardiac CT scan. Metformin was withhold for 48 hours before and after contrast administration in all patients. Patients were assessed for risk of contrast induced nephropathy (CIN) based on GFR rather than on the absolute level of serum creatinine. GFR > 60 mL/min: normal or near-normal renal function and extremely low risk for CIN. These patients required no specific prophylaxis or oral hydration was given in patients with multiple risk factors. GFR of 30 to 60 mL/min: moderate renal dysfunction and low-to-moderate risk for CIN, IV dyhration of 1000 mL D5W with 3 mL/kg/h for 1 hour prior to contrast administration and 2 mL/kg/h after contrast administration; GFR < 30 mL/min: severe renal dysfunction and high risk for CIN, hydration and IV sodium bicarbonate regimen was used with NaHCO 3 , 3 amps (150 mEq) in 850 mL D5W at 3 mL/kg/h for 1 hour before contrast administration and at 2 mL/kg/h after contrast administration; GFR < 15mL/min: renal failure. These patients were usually required to be on dialysis and no CCTA with contrast was performed without dialysis or backup of dialysis if renal failure deteriorated.
Acquisition of Cardiac CT Images
Anterior-posterior and lateral chest scout views were first obtained for planning. Calcium score images were obtained using 64 x 2.5 mm x 400 ms with 120 kVp and 50-75 mAs to cover the entire heart and proximal ascending aorta. A positive calcium score was defined by 130 HU with an area of 1 mm 2 or greater. The amount of calcium was quantified using the Agatston scoring method [12] . CCTA data were obtained using the thinnest slice thickness and fastest rotation (0.6 mm x 64 x 400 ms) for Phillips 64 MDCT scanner and (0.625 x 16 x 350ms/rotation) for GE, Lightspeed 16 MDCT scanner. A pitch of 0.25 was used. Tube current of 750-1050 mAs/slice (350-450 mA) was selected for CCTA. Higher tube current was used for obese patients. Tube voltage of 120 kVp was routinely used for CCTA scan. In obese patients (more than 300 lbs), a higher tube voltage of 140 kV was used. The right antecubital vein was usually the preferred site for contrast injection with an 18 gauge IV line. Dual injector was used for injection of contrast (Visipaque) and chasing (70% saline and 30% contrast mixture) solution. Contrast injection rate was 4.5-5.5 ml depending on patient body surface area, heart size and function. A higher rate was used for patient with an enlarged heart and poor LV function. A contrast dose of 70-90 ml of Visipaque was given depending on scan length and time: (total scanning time x injection flow rate) + (bolus tracking time delay to the start of CT scan x injection flow rate). The mixture of saline and contrast in the chasing solution is to ensure visualization of RV cavity but not to overshadow RCA visualization.
Bolus tracking method was used for timing of the start of scanning after beginning of the contrast injection. The ascending aorta at bifurcation of pulmonary artery was used as bolus tracking locator site. The threshold for CT unit was set to 140 HU to trigger the scan with a 5-6 second delay. All calcium and cardiac CT scans were reviewed by an experienced cardiologist (CC) as a part of routine clinical report. Extracardiac CT findings were reported by radiologists.
Reconstruction
Raw CTA scan data were retrospectively reconstructed initially at 75% of R-R interval to coincide with diastasis and 35-45% to capture isovolumic relaxation time and endsystole where coronary motion is relatively stable. Additional phases with 5% increments were reconstructed such as 70%-80%, if motion artifacts were noted from the 75% data. Adaptive cardiac multicycle (or multi-segment) algorithms were used to combine data from multiple cardiac cycles (up to 4) to optimize temporal resolution [13] .
CCTA Interpretation
Source images were reviewed and processed with straightened and curved multi-planar projection reconstruction (MPR), maximal intensity projection (MIP) and cross-sectional views. Measurements of degree of stenosis on CCTA were performed on straighten MPR views and cross-sectional images using Phillips work station. The coronary trees were segmented according to modified American Heart Association classification. The segments were investigated for luminal narrowing. Segments were graded as small (diameter <1.5 mm) which were excluded from analysis. Presence of calcified plaque was defined by any discernible structure in the coronary arterial wall with any focal or dense calcification as defined by a CT density of HU of >130 [14] . Non-calcified plaques were defined as any discernible structure in the coronary arterial wall with a CT density less than the contrast enhanced lumen but different from the surrounding connective tissues without any focal or dense calcification. Degree of coronary artery stenosis was expressed as % diameter stenosis. Assessment of degree of stenosis was based on the quantitative measurement and classified as mild (<30%), mild to moderate (30-49%), moderate (50-70%), severe (>70%) coronary artery stenosis. A significant coronary artery stenosis was defined as 50% or greater diameter stenosis. Clinical decision making regarding, medical therapy, further diagnostic testing such as cardiac catheterization and angiography, or revascularization (percutaneous or surgical) was at the discretion of the referring physician.
Statistical Analysis
The continuous variables were analyzed using one way ANOVA. Non-continuous variables were analyzed with ChiSquare test. Stepwise, multi-variant linear regression analysis was performed to test factors (age, gender, race, hypertension, dyslipidemia, diabetes, family history of premature coronary artery disease, smoking) related to significant coronary artery stenosis with zero calcium score. Numeric data were expressed as mean +/-standard deviation. P value of 0.05 or less was considered as statistically significant.
RESULTS
Of 737 consecutive patients included in this study, there were 383 females and 354 males with age of 57.4 +/-12.9 (range 26-89) years. The patient population included 44% African Americans, 35% Caucasians, 21% other races (6.6% Hispanics, 5.2% Asians, and 1.7% Native Americans, 7.5% undefined). There were 516 outpatients, and 221 inpatients or patients admitted through the emergency room (See Table  1 ). There were 315 patients who had chest pain syndrome, 171 patients who had equivocal/positive stress test with dyspnea or palpitations and 251 patients had both of chest pain and equivocal/positive stress test.
Of 737 patients, there were 351 patients with zero calcium score and 386 patients with a positive calcium score. In 386 patients with a positive calcium score, 170 patients were white and 216 patients were non-white. The prevalence of positive calcium score was 65.9% (170/258 patients) for white patients which was significantly higher (p<0.01) than non-white patients (45.1%, 216/479 patients). There was no significant difference (p=NS) in age (57.3 +/-14.4 vs. 56.6 +/-13.1 years white vs. non-white) or gender (female/male ratio 163/121 vs. 270/232 patients for white vs. non-white) distribution in white and non-white patients.
A significant coronary artery stenosis was found in 211 of the 737 patients (28.6%), 88/258 (34.1%) patients for white and 122/479 (25.5%) patients for non-white (p<0.05). Of these 211 patients with significant CAD, 186 patients 88.2% had positive calcium scores Fig. (1A) , and 25 (11.8%) had zero calcium scores in spite of significant coronary stenosis Fig. (1B) (p<0.01) (See Table 2 ). The latter patients had obstructive coronary artery disease with non-calcified plaques, and thus, were not detected by MDCT calcium scan prior to coronary CT angiography.
The prevalence of significant coronary artery stenosis is 48.3% (186/385 patients) in patients with a positive calcium score in this study population with a clinically suspicious CAD. There was no significant difference between Caucasian patients with a positive calcium score and significant CAD (81/170 patients, 47.6%) and nonCaucasian patients (105/216 patients, 48.6%). In patients with a positive calcium score on MDCT calcium scan and significant coronary artery stenosis, the majority of patients (60.2%, Table 3 ) had a calcium core of 400 or more. Of note, 12.3% of patients with a significant coronary artery stenosis had a minimal calcium score of <100 but >0.
From the 526 patients without significant stenosis on CCTA, there were 326 patients who had zero calcium scores and 199 patients had a positive calcium score. Of 326 patients with zero calcium score, there were 80 white patients and 246 non-white patients.
The prevalence of significant CAD was 7.1% (25/351 patients) in patients with a zero calcium score in this study. There was no significant difference (p=NS) between the prevalence of significant CAD for white patients (9.1%, 8/88 patients) and for non-white patients (6.5%, 17/263 patients) with a zero calcium score. There was no difference of the prevalence of significant coronary artery stenosis between 63 of 221 (28.5%) inpatients or emergency department patients, and 148 of 516 (28.7%) outpatients (p=NS). Duration of chest pain of significant CAD with positive calcium (2.5+/-1.8 months) was not different from that of significant CAD patients with negative calcium (2.2 +/-2.1 months, p=NS). There was tendency toward a higher proportion of a significant coronary artery stenosis without calcified plaque in non-Caucasian patients (13.9%, 17/122 patients) with significant CAD than that of Caucasian (9%, 8/89) patients with significant CAD but it did not reach statistical significance (p =NS). Traditional coronary risk factors were compared between the two groups of patients with significant coronary stenosis, with zero calcium scores versus those with positive calcium scores, using stepwise multivariate linear regression analysis. The only two factors that reached statistical significance were age and female gender. Patients with calcium scores of zero were younger (p<0.01) than those with positive calcium score. There was a wide range of age in patients with zero calcium scores and significant CAD (26-80 years) as compared to those with positive calcium scores (44-89 years). In 25 patients with zero calcium scores and significant CAD, 18 (72%) patients were 50 years or older and 9/25 (36%) patients were 60 years or older. In 25 patients with zero calcium score and significant coronary artery stenosis, 15 (60%) patients were Fig. (1) . A: MDCT coronary angiography shows calcified plaque with significant LAD stenosis (arrow). Note that there is also significant left main stenosis. Fig. (1) . B: MDCT coronary angiography shows non-calcified plaque with significant LAD stenosis (arrow) after sublingual nitroglycerine. Comparison between CT coronary angiography and cardiac catheterization angiography: For the entire group, there were 43 patients who had invasive coronary angiography within 3 months of CT angiography and without interval events. 39 of these 43 patients, had significant coronary artery stenosis on invasive cardiac catheterization coronary angiography; 37 of the 39 patients had significant coronary artery stenosis (>50%) on CT coronary angiography (sensitivity of 95%). Only two patients with >50% coronary artery stenosis on catheterization were slightly underestimated by CT (25-49% coronary stenosis by CT). The remaining 4 of the 43 patients, did not have a significant coronary artery stenosis on CT, nor on cardiac catheterization. This was too few to calculate specificity. Of 25 patients with significant coronary artery stenosis with zero calcium score on CT, 18 (72%) patients underwent cardiac catheterization and were all confirmed by invasive coronary angiography to have a significant coronary artery stenosis Fig. (1B and C) . Thirteen of the 18 (72%) patients with significant CAD with zero calcium score who had catheterization coronary angiography underwent percutaneous coronary intervention (n=11) with stents or coronary bypass surgery (n=2). The remaining patients were treated medically.
DISCUSSION
The main findings of this study are: 1) A significant number (11.8%) of patients with significant coronary artery stenosis on CT coronary angiography have a zero calcium score on CT calcium scan in a large, diverse, mostly nonCaucasian patient population, 2) There is no significant racial difference in incidence of significant CAD with zero calcium score in Caucasian and non-Caucasian patients, 3) Significant CAD without detectable calcium deposit is more common in younger patients but can occur in as old as 80 years old, 4) Females are more likely to have significant coronary artery stenosis without positive calcium scan than males. Thus, a negative calcium scan does not exclude significant coronary artery disease, particularly in younger and female patients either in Caucasian or non-Caucasian population. 5) Significant CAD with non-calcified plaques is not benign as more than 70% patients with non-calcified plaques required percutaneous or surgical coronary intervention. Therefore, CT coronary angiography should be performed even in patients with no detectable calcium deposit on the coronary system to exclude significant coronary artery stenosis in clinically suspicious CAD.
CALCIUM SCORE AND SIGNIFICANT CAD
Calcium scores of greater than 100 HU have been described as an independent risk factor for coronary artery disease [15] . Previous studies show inconsistent results regarding prevalence of patients with significant CAD without a positive calcium score. Significant CAD with zero calcium score varied from negligible of <1% to 16% of total patients with significant CAD. The difference may be caused by differences in patient selection (symptomatic or asymptomatic screening population, racial variations), duration of follow-up and definition of significant CAD. Difference in prevalence of significant positive calcium deposit in the coronary artery system between Caucasian and non-Caucasian was demonstrated by Detrano et al. [16] . Whether or not the racial difference may contribute to the discrepancy in prevalence of significant CAD without calcium in previous studies was not clear. In a diverse population consisting of primarily Africa-Americans, we demonstrated in this study that the majority of patients with a significant coronary artery stenosis had a calcium score of 100 or more (76%). Furthermore, 44% of patients with significant coronary artery stenosis had a calcium score of 1000 or more. However, there was 24.1% of patients with significant coronary artery stenosis who had a calcium score less than 100. In fact, 11.8% patients with significant coronary artery stenosis had no detectable calcium deposit in the coronary artery at all. Patients with significant coronary disease and zero coronary calcium are generally younger and more likely to be female than those with detectable calcium deposit in the coronary artery. The difference in average ages is expected as calcification is more prevalent in older adults and plaques are more likely to calcify over time [17] . However, there was a wide range of age in patients with zero calcium scores and significant CAD (26-80 years) as compared to those with positive calcium scores (44-89 years). In fact, 18/25 (72%) of patients with zero calcium scores and significant CAD were 50 years or older and 9/25 (36%) were 60 years or older. This demonstrates that a zero calcium score can not be used to rule out significant coronary artery disease even in the older population of patients of age of 60 years or older. The reason for a significant higher incidence in women than men with significant coronary disease without detectable calcium in the coronary system is not clear [5] . Whether it reflects late occurrence of coronary artery disease after 55 years old in females or female hormones that influence the composites of coronary artery atherosclerotic plaques would need further study [18] . Non-Caucasian patients have a tendency toward a slightly higher proportion of significant CAD with noncalcified plaque and zero calcium score than white patients. However, the differences did not reach a statistical significance (p=NS). Caucasian had both a higher incidence of significant CAD and a higher incidence of positive calcium scan in this study while proportion of patients with significant CAD who had a positive calcium scan is not different between Caucasian (47.6%) and non-caucasian (48.6%) patents. The tendency of a higher calcium score in Caucasian patients is consistent with results of Detrano et al's study in which prevalence of coronary calcification (calcium score > 0) is higher in white men (70.4%) or white women (44.7%) than black men (56.6%) or women (37%), Hispanic men (56.6%) or women (34.8%), or Chinese men (59.2%) or women (41.9%); however, predictive value of calcium score for coronary events was not different between white and non-white races [16] .
COMPARED WITH PREVIOUE STUDIES
The high percentage of patients with significant CAD without positive calcium scan in this study is consistent with results of Schenker et al. [4] and Hausleiter et al. [19] . In the study of Hausleiter et al., 10 of 108 (9.3%) patients with significant CAD with a zero calcium score in patients with clinically suspicious CAD either with chest pain, significant arrhythmia or positive stress test. In the study of Schenker et al., the incidence of ischemia on PET was 16% of patients with no calcium on MDCT calcium scan. Although the racial distribution is not clear in their study, patients included in their study were similar to our study and were all-physician referred for evaluation of CAD based on cardiac symptoms or other evidence of intermediate-to-high risk of CAD. In contrast, in prior studies which reported low incidence of significant CAD without positive cardiac scan, patients were largely screening populations with or without cardiac symptom [17] , or symptomatic patients with high probability of CAD were referred for cardiac catheterization in mostly Caucasian patients by Knez et al. and Budoff et al. [5, 20] .
RATIONALE OF NON-CALCIFIED PLAQUES FOR OBSTRUCTIVE CAD
The cause of significant CAD without a positive calcium scan is unclear. It may be related to limitations of current calcium CT scan and various compositions of different stages of atherosclerotic plaques. Histopathological plaque characteristic studies demonstrated that microcalcifications can be seen in various stages of the atherosclerotic disease [21] . The calcifications are dense and become identifiable on CT scans in more advanced stage of atherosclerotic plaques. At least 1mm 2 of calcium deposit or 3 pixels of calcium density is required to identify calcium on CT scans. Although calcium score correlates linearly with total plaque area on histopathological studies by Rumberger et al. [15] , it was noted that calcified plaques only account for 20% of the total plaque burden. The vast majority of plaques are noncalcified at early stages of plaque formation and may not necessarily be obstructive. Furthermore, the eroded plaques seen in pre-menopausal women have a much lower incidence of calcification [22] .
LIMITATIONS
While our diverse patient population with coronary CTA and calcium scores is one of the largest series of patients in the literature, we recognize that there are limitations in the present study. This study is retrospective. Patients included in this study were referred to coronary CTA with selection bias by referring physician. However, all patients were clinically suspicious for significant CAD. The majority of our patients suffered from chest pain and many also had abnormal or equivocal stress testing. Not all patients underwent an exercise or pharmacological stress test either pre-CCTA or post CCTA in this study, data might have looked differently if all patients had underwent an exercise stress test.
CONCLUSION
A negative calcium scan does not preclude the need for CT coronary angiography in patients with clinically suspicious coronary artery disease in Caucasian or nonCaucasian patients. CT coronary angiography provides not only the degree of coronary stenosis in patients with positive calcium scans, but also can detect coronary artery stenosis in patients with negative calcium scans, thus, providing incremental value over calcium scan alone in clinically suspicious CAD patients even with no detectable calcium deposit in the coronary artery.
